Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
Phytother Res ; 28(12): 1806-15, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25087858

ABSTRACT

Kielmeyera rugosa is a medicinal plant known in Northeastern Brazil as 'pau-santo', and it is used in the treatment of several tropical diseases such as malaria, schistosomiasis, and leishmaniasis. We evaluated antihyperalgesic and anti-inflammatory activities of methanol stem extract of K. rugosa (MEKR) in mice. The mechanical hyperalgesia induced by carrageenan and tumor necrosis factor-alpha (TNF-α), prostaglandin E2 , and dopamine were assessed. We also investigated the anti-inflammatory effect of MEKR on carrageenan-induced pleurisy and paw edema. Ninety minutes after the treatment, the animals were submitted to an imunofluorescence for Fos protein. MEKR (100, 200, and 400 mg/kg; p.o.) inhibited the development of mechanical hypernociception and edema. MEKR significantly decreased TNF-α and interleukin 1ß levels in pleural lavage and suppressed the recruitment of leukocytes. MEKR (1, 10, and 100 mg/mL) did not produce cytotoxicity, determined using the methyl-thiazolyl-tetrazolium assay in vitro. The locomotor activity was not affected. MEKR activated significantly the bulb olfactory, piriform cortex, and periaqueductal gray of the central nervous system. Our results provide first time evidence to propose that MEKR attenuates mechanical hyperalgesia and inflammation, in part, through an activation of central nervous system areas, mainly the periaqueductal gray and piriform cortex areas.


Subject(s)
Analgesics/pharmacology , Anti-Inflammatory Agents/pharmacology , Central Nervous System/drug effects , Cytokines/metabolism , Hyperalgesia/drug therapy , Inflammation/drug therapy , Plant Extracts/pharmacology , Animals , Carrageenan/adverse effects , Dinoprostone/metabolism , Dopamine/metabolism , Edema/drug therapy , Interleukin-1beta/metabolism , Magnoliopsida/chemistry , Male , Mice , Periaqueductal Gray/drug effects , Piriform Cortex/drug effects , Plant Stems/chemistry , Pleurisy/drug therapy , Proto-Oncogene Proteins c-fos/metabolism , Tumor Necrosis Factor-alpha/metabolism
2.
Oxid Med Cell Longev ; 2013: 194192, 2013.
Article in English | MEDLINE | ID: mdl-23577220

ABSTRACT

2-[(2,6-Dichlorobenzylidene)amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carbonitrile, 5TIO1, is a new 2-aminothiophene derivative with promising pharmacological activities. The aim of this study was to evaluate its antioxidant activity in different areas of mice central nervous system. Male Swiss adult mice were intraperitoneally treated with Tween 80 dissolved in 0.9% saline (control group) and 5TIO1 (0.1, 1, and 10 mg kg(-1)). Brain homogenates-hippocampus, striatum, frontal cortex, and cerebellum-were obtained after 24 h of observation. Superoxide dismutase and catalase activities, lipid peroxidation and nitrite content were measured using spectrophotometrical methods. To clarify the 5TIO1's mechanism on oxidative stress, western blot analysis of superoxide dismutase and catalase was also performed. 5TIO1 decreased lipid peroxidation and nitrite content in all brain areas and increased the antioxidant enzymatic activities, specially, in cerebellum. The data of Western blot analysis did not demonstrate evidence of the upregulation of these enzymes after the administration of this compound. Our findings strongly support that 5TIO1 can protect the brain against neuronal damages regularly observed during neuropathologies.


Subject(s)
Antioxidants/pharmacology , Brain/metabolism , Oxidative Stress , Schiff Bases/pharmacology , Thiophenes/pharmacology , Animals , Antioxidants/chemistry , Brain/drug effects , Catalase/metabolism , Cerebellum/enzymology , Cerebellum/metabolism , Corpus Striatum/enzymology , Corpus Striatum/metabolism , Frontal Lobe/enzymology , Frontal Lobe/metabolism , Hippocampus/enzymology , Hippocampus/metabolism , Injections, Intraperitoneal , Lipid Peroxidation , Male , Mice , Nitrites/metabolism , Oxidative Stress/drug effects , Schiff Bases/chemistry , Superoxide Dismutase/metabolism , Thiophenes/chemistry
3.
Braz J Med Biol Res ; 42(2): 164-7, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19274343

ABSTRACT

Chaperone members of the protein disulfide isomerase family can catalyze the thiol-disulfide exchange reaction with pairs of cysteines. There are 14 protein disulfide isomerase family members, but the ability to catalyze a thiol disulfide exchange reaction has not been demonstrated for all of them. Human endoplasmic reticulum protein chaperone thio-oxidoreductase (ERp18) shows partial oxidative activity as a protein disulfide isomerase. The aim of the present study was to evaluate the participation of ERp18 in gonadotropin-releasing hormone receptor (GnRHR) expression at the plasma membrane. Cos-7 cells were cultured, plated, and transfected with 25 ng (unless indicated) wild-type human GnRHR (hGnRHR) or mutant GnRHR (Cys14Ala and Cys200Ala) and pcDNA3.1 without insert (empty vector) or ERp18 cDNA (75 ng/well), pre-loaded for 18 h with 1 microCi myo-[2-3H(N)]-inositol in 0.25 mL DMEM and treated for 2 h with buserelin. We observed a decrease in maximal inositol phosphate (IP) production in response to buserelin in the cells co-transfected with hGnRHR, and a decrease from 20 to 75 ng of ERp18 compared with cells co-transfected with hGnRHR and empty vector. The decrease in maximal IP was proportional to the amount of ERp18 DNA over the range examined. Mutants (Cys14Ala and Cys200Ala) that could not form the Cys14-Cys200 bridge essential for plasma membrane routing of the hGnRHR did not modify maximal IP production when they were co-transfected with ERp18. These results suggest that ERp18 has a reduction role on disulfide bonds in wild-type hGnRHR folding.


Subject(s)
Cell Membrane/metabolism , Protein Disulfide Reductase (Glutathione)/metabolism , Receptors, LHRH/metabolism , Animals , Buserelin/metabolism , Buserelin/pharmacology , COS Cells , Cell Membrane/chemistry , Chlorocebus aethiops , Humans , Inositol Phosphates/metabolism , Mutation , Protein Disulfide Reductase (Glutathione)/genetics
4.
Braz. j. med. biol. res ; 42(2): 164-167, Feb. 2009. graf
Article in English | LILACS | ID: lil-506877

ABSTRACT

Chaperone members of the protein disulfide isomerase family can catalyze the thiol-disulfide exchange reaction with pairs of cysteines. There are 14 protein disulfide isomerase family members, but the ability to catalyze a thiol disulfide exchange reaction has not been demonstrated for all of them. Human endoplasmic reticulum protein chaperone thio-oxidoreductase (ERp18) shows partial oxidative activity as a protein disulfide isomerase. The aim of the present study was to evaluate the participation of ERp18 in gonadotropin-releasing hormone receptor (GnRHR) expression at the plasma membrane. Cos-7 cells were cultured, plated, and transfected with 25 ng (unless indicated) wild-type human GnRHR (hGnRHR) or mutant GnRHR (Cys14Ala and Cys200Ala) and pcDNA3.1 without insert (empty vector) or ERp18 cDNA (75 ng/well), pre-loaded for 18 h with 1 µCi myo-[2-3H(N)]-inositol in 0.25 mL DMEM and treated for 2 h with buserelin. We observed a decrease in maximal inositol phosphate (IP) production in response to buserelin in the cells co-transfected with hGnRHR, and a decrease from 20 to 75 ng of ERp18 compared with cells co-transfected with hGnRHR and empty vector. The decrease in maximal IP was proportional to the amount of ERp18 DNA over the range examined. Mutants (Cys14Ala and Cys200Ala) that could not form the Cys14-Cys200 bridge essential for plasma membrane routing of the hGnRHR did not modify maximal IP production when they were co-transfected with ERp18. These results suggest that ERp18 has a reduction role on disulfide bonds in wild-type hGnRHR folding.


Subject(s)
Animals , Humans , Cell Membrane/metabolism , Protein Disulfide Reductase (Glutathione)/metabolism , Receptors, LHRH/metabolism , Buserelin/metabolism , Buserelin/pharmacology , Chlorocebus aethiops , COS Cells , Cell Membrane/chemistry , Inositol Phosphates/metabolism , Mutation , Protein Disulfide Reductase (Glutathione)/genetics
5.
Braz. j. med. biol. res ; 38(11): 1669-1675, Nov. 2005. ilus
Article in English | LILACS | ID: lil-414720

ABSTRACT

We determined if the dorsal raphe nucleus (DRN) exerts tonic control of basal and stimulated sodium and water intake. Male Wistar rats weighing 300-350 g were microinjected with phosphate buffer (PB-DRN, N = 11) or 1 æg/0.2 æl, in a single dose, ibotenic acid (IBO-DRN, N = 9 to 10) through a guide cannula into the DRN and were observed for 21 days in order to measure basal sodium appetite and water intake and in the following situations: furosemide-induced sodium depletion (20 mg/kg, sc, 24 h before the experiment) and a low dose of dietary captopril (1 mg/g chow). From the 6th day after ibotenic acid injection IBO-DRN rats showed an increase in sodium appetite (12.0 ± 2.3 to 22.3 ± 4.6 ml 0.3 M NaCl intake) whereas PB-DRN did not exceed 2 ml (P < 0.001). Water intake was comparable in both groups. In addition to a higher dipsogenic response, sodium-depleted IBO-DRN animals displayed an increase of 0.3 M NaCl intake compared to PB-DRN (37.4 ± 3.8 vs 21.6 ± 3.9 ml 300 min after fluid offer, P < 0.001). Captopril added to chow caused an increase of 0.3 M NaCl intake during the first 2 days (IBO-DRN, 33.8 ± 4.3 and 32.5 ± 3.4 ml on day 1 and day 2, respectively, vs 20.2 ± 2.8 ml on day 0, P < 0.001). These data support the view that DRN, probably via ascending serotonergic system, tonically modulates sodium appetite under basal and sodium depletion conditions and/or after an increase in peripheral or brain angiotensin II.


Subject(s)
Animals , Male , Rats , Ibotenic Acid/toxicity , Excitatory Amino Acid Agonists/toxicity , Appetite/drug effects , Drinking/drug effects , Raphe Nuclei/drug effects , Sodium, Dietary , Appetite/physiology , Buffers , Captopril/pharmacology , Furosemide/pharmacology , Drinking/physiology , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Sodium Potassium Chloride Symporter Inhibitors/pharmacology , Phosphates , Rats, Wistar , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...